Inventor · disambiguated record
Marlene L. Cohen
Also filed as: COHEN MARLENE · COHEN MARLENE L · COHEN MARLENE LOIS
28 granted patents·6 pending applications·422 citations·filing 1983–2005
97Inventor score
Top patents by PatentIndex Score
34 records- 0192US4921982A5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT3 antagonistsLILLY CO ELI·Filed 1989·Granted May 1, 1990·33 cites·2 claims
- 0286US6117882A5-HT4 agonists and antagonistsLILLY CO ELI·Filed 1999·Granted Sep 12, 2000·63 cites·12 claims
- 0384US5364863ASpecific 5-HT3 antagonistsLILLY CO ELI·Filed 1993·Granted Nov 15, 1994·20 cites·12 claims
- 0479US5698571A5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraineLILLY CO ELI·Filed 1994·Granted Dec 16, 1997·36 cites·20 claims
- 0575US5441961ASubstituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolinesLILLY CO ELI·Filed 1992·Granted Aug 15, 1995·12 cites·15 claims
- 0674US6069152A5-HT4 agonists and antagonistsLILLY CO ELI·Filed 1997·Granted May 30, 2000·31 cites·12 claims
- 0772US5043341AN-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamidesLILLY CO ELI·Filed 1990·Granted Aug 27, 1991·25 cites·26 claims
- 0872US4563461ASelective method for blocking 5HT2 receptorsLILLY CO ELI·Filed 1983·Granted Jan 7, 1986·13 cites·4 claims
- 0970US5705519AMethod for treating 5-HT2B receptor related conditionsLILLY CO ELI·Filed 1995·Granted Jan 6, 1998·11 cites·13 claims
- 1070US4902691AHeteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptorsLILLY CO ELI·Filed 1988·Granted Feb 20, 1990·14 cites·25 claims
- 1169US5744482ASerotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraineLILLY CO ELI·Filed 1994·Granted Apr 28, 1998·34 cites·5 claims
- 1267US5688807AMethod for treating 5HT2B receptor related conditionsLILLY CO ELI·Filed 1995·Granted Nov 18, 1997·24 cites·13 claims
- 1365US5141944AN-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamidesLILLY CO ELI·Filed 1991·Granted Aug 25, 1992·8 cites·6 claims
- 1463US5442078AIntermediates for specific 5-HT3 antagonistsLILLY CO ELI·Filed 1994·Granted Aug 15, 1995·5 cites·2 claims
- 1562US2006111385A1Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereofMOLINO BRUCE F·Filed 2004·Application pending·0 cites
- 1661US2006111386A1Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereofAMR TECHNOLOGY INC·Filed 2005·Application pending·0 cites
- 1759US5739146ASubstituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolinesLILLY CO ELI·Filed 1995·Granted Apr 14, 1998·6 cites·28 claims
- 1855US5563148ASpecific 5-HT3 antagonistsLILLY CO ELI·Filed 1995·Granted Oct 8, 1996·4 cites·28 claims
- 1954US5817676AIndazolecarboxamidesLILLY CO ELI·Filed 1997·Granted Oct 6, 1998·12 cites·3 claims
- 2053US2006111393A14-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotoninMOLINO BRUCE F·Filed 2004·Application pending·0 cites
- 2153US2006111394A1Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotoninMOLINO BRUCE F·Filed 2004·Application pending·0 cites
- 2251US4762842ASelective method for blocking 5HT2 receptorsLILLY CO ELI·Filed 1987·Granted Aug 9, 1988·16 cites·14 claims
- 2351US2006111396A14-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotoninAMR TECHNOLOGY INC·Filed 2005·Application pending·0 cites
- 2451US2006111395A1Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotoninAMR TECHNOLOGY INC·Filed 2005·Application pending·0 cites
- 2550US5736544ANaphthylpiperazinyl compounds useful for treating 5HT2B receptor mediated conditionsLILLY CO ELI·Filed 1996·Granted Apr 7, 1998·9 cites·7 claims
- 2649US5674875AMethod of blocking human 5-hydroxytryptamine-2 receptorsLILLY CO ELI·Filed 1995·Granted Oct 7, 1997·11 cites·2 claims
- 2749US4713384ASelective method for blocking 5HT2 receptorsLILLY CO ELI·Filed 1985·Granted Dec 15, 1987·5 cites·2 claims
- 2845US5880134AMethod for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptorLILLY CO ELI·Filed 1996·Granted Mar 9, 1999·8 cites·14 claims
- 2944US5886003AMethods of treating or ameliorating the symptoms of venomous bites and stingsLILLY CO ELI·Filed 1997·Granted Mar 23, 1999·7 cites·11 claims
- 3043US4520024AMethod of selectively blocking peripheral vascular serotonergic receptorsLILLY CO ELI·Filed 1983·Granted May 28, 1985·6 cites·1 claims
- 3142US5798367AIndazolecarboxamidesLILLY CO ELI·Filed 1997·Granted Aug 25, 1998·4 cites·9 claims
- 3234US4914107AMethod for selectively blocking 5-HT2 receptorsLILLY CO ELI·Filed 1989·Granted Apr 3, 1990·2 cites·4 claims
- 3334US4810710A4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraineLILLY CO ELI·Filed 1988·Granted Mar 7, 1989·3 cites·2 claims
- 3430US5840747ACalcium channel antagonistsLILLY CO ELI·Filed 1995·Granted Nov 24, 1998·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Marlene L. Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →